English  |  正體中文  |  简体中文  |  2826152  
???header.visitor??? :  31812262    ???header.onlineuser??? :  789
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"pei jer chen"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 526-550 of 883  (36 Page(s) Totally)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-07-03T03:34:08Z Erratum: Report from a Viral Hepatitis Policy Forum on implementing the WHO framework for global action on viral hepatitis in North Asia (Journal of Hepatology (2013) 59 (1073-1080)) Chen D.-S.; Locarnini S.; Wait S.; Bae S.-H.; PEI-JER CHEN; Fung J.Y.Y.; Kim H.S.; Lu S.-N.; Sung J.; Tanaka J.; Wakita T.; Ward J.; Wallace J.
臺大學術典藏 2021-07-03T03:34:08Z A procalcitonin-based algorithm to guide antibiotic therapy in secondary peritonitis following emergency surgery: A prospective study with propensity score matching analysis Huang T.-S.; Huang S.-S.; Shyu Y.-C.; Lee C.-H.; Jwo S.-C.; PEI-JER CHEN; Chen H.-Y.
臺大學術典藏 2021-07-03T03:34:08Z Hepatitis B virus: Pathogenesis and host immune response Yang H.-C.; Yeh S.-H.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:07Z The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo Lin S.-R.; Yang H.-C.; Kuo Y.-T.; Liu C.-J.; Yang T.-Y.; Sung K.-C.; Lin Y.-Y.; Wang H.-Y.; Wang C.-C.; Shen Y.-C.; Wu F.-Y.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:07Z Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model Tzeng H.-T.; Tsai H.-F.; Chyuan I.-T.; Liao H.-J.; Chen C.-J.; PEI-JER CHEN; Hsu P.-N.
臺大學術典藏 2021-07-03T03:34:07Z Association of adjuvant antiviral therapy with risk of cancer progression and deaths in patients with hepatitis-B-virus-related hepatocellular carcinoma following curative treatment: A nationwide cohort study Yeh Y.-C.; Liu C.-J.; Kuo R.N.; Lai C.-L.; Shau W.-Y.; PEI-JER CHEN; Lai M.-S.
臺大學術典藏 2021-07-03T03:34:06Z Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription Wu C.-H.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:34:06Z Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma Liu J.; Yang H.-I.; Lee M.-H.; Lu S.-N.; Jen C.-L.; Batrla-Utermann R.; Wang L.-Y.; You S.-L.; Hsiao C.K.; PEI-JER CHEN; Chen C.-J.
臺大學術典藏 2021-07-03T03:34:06Z The driving circuit of HBx and androgen receptor in HBV-related hepatocarcinogenesis Wang S.-H.; Yeh S.-H.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:06Z Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence Liu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN
臺大學術典藏 2021-07-03T03:34:05Z Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870 Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; PEI-JER CHEN; Lee S.-D.; Yu M.-W.
臺大學術典藏 2021-07-03T03:34:05Z Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection Colvin R.A.; Tanwandee T.; Piratvisuth T.; Thongsawat S.; Hui A.J.; Zhang H.; Ren H.; PEI-JER CHEN; Chuang W.-L.; Sobhonslidsuk A.; Li R.; Qi Y.; Praestgaard J.; Han Y.; Xu J.; Stein D.S.; Chien R.-N.; Flisiak R.; Jablkowski M.; Liaw Y.-F.; Sung J.J.-Y.
臺大學術典藏 2021-07-03T03:34:05Z A Lego?-like swappable fluidic module for bio-chem applications Hsieh Y.-F.; Yang A.-S.; Chen J.-W.; Liao S.-K.; Su T.-W.; Yeh S.-H.; PEI-JER CHEN; Chen P.-H.
臺大學術典藏 2021-07-03T03:34:04Z Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Su T.-H.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-07-03T03:34:04Z Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: Comparison of genotypes B and C at various immune stages Liu C.-J.; Chen T.-C.; PEI-JER CHEN; Wang H.-Y.; Tseng T.-C.; Cheng H.-R.; Liu C.-H.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:04Z New insights into the evolutionary rate of hepatitis B virus at different biological scales Lin Y.-Y.; Liu C.; Chien W.-H.; Wu L.-L.; Tao Y.; Wu D.; Lu X.; Hsieh C.-H.; PEI-JER CHEN; Wang H.-Y.; Kao J.-H.; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:04Z Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan Chen C.-L.; Yang J.-Y.; Lin S.-F.; Sun C.-A.; Bai C.-H.; You S.-L.; Chen C.-J.; Kao J.-H.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:03Z Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota Chou H.-H.; Chien W.-H.; Wu L.-L.; Cheng C.-H.; Chung C.-H.; Horng J.-H.; Ni Y.-H.; Tseng H.-T.; Wu D.; Lu X.; Wang H.-Y.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:34:03Z Elevated p53 promotes the processing of miR-18a to decrease estrogen receptor-α in female hepatocellular carcinoma Li C.-L.; Yeh K.-H.; Liu W.-H.; Chen C.-L.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:34:03Z Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection Song L.-W.; Liu P.-G.; Liu C.-J.; Zhang T.-Y.; Cheng X.-D.; Wu H.-L.; Yang H.-C.; Hao X.-K.; Yuan Q.; Zhang J.; Kao J.-H.; Chen D.-S.; PEI-JER CHEN; Xia N.-S.
臺大學術典藏 2021-07-03T03:34:02Z Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; Su T.-H.; Yang H.-C.; Liu C.-J.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:02Z Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; Su T.-H.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:02Z Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; Su T.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:34:01Z Rapid fluorescent lateral-flow immunoassay for hepatitis B virus genotyping Song L.-W.; Wang Y.-B.; Fang L.-L.; Wu Y.; Yang L.; Chen J.-Y.; Ge S.-X.; Zhang J.; Xiong Y.-Z.; Deng X.-M.; Min X.-P.; Zhang J.; PEI-JER CHEN; Yuan Q.; Xia N.-S.
臺大學術典藏 2021-07-03T03:34:01Z Predicting hepatitis B virus (HBV) surface antigen seroclearance in HBV e antigen-negative patients with chronic hepatitis B: External validation of a scoring system Liu J.; Tseng T.-C.; Yang H.-I.; Lee M.-H.; Batrla-Utermann R.; Jen C.-L.; Lu S.-N.; Wang L.-Y.; You S.-L.; PEI-JER CHEN; Chen C.-J.; Kao J.-H.

Showing items 526-550 of 883  (36 Page(s) Totally)
<< < 17 18 19 20 21 22 23 24 25 26 > >>
View [10|25|50] records per page